| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |